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In the UK, a number of transmissible strains of Pseudomonas aeruginosa have
been identiﬁed, the most common of which is the Liverpool Epidemic Strain
(LES), which has been associated with causing greater morbidity of CF patients,
superinfection, and the infection of non-CF parents of a CF patient. Using a series
of phenotypic and genotypic tests, we analysed ﬂuctuations within populations
of P. aeruginosa (LES) during pulmonary exacerbation. Three sequential sputum
samples were collected from each patient: (1) on presentation with exacerbation
at the CF unit, (2) three days into intravenous (IV) antibiotic treatment and (3)
at the end of therapy. From each sample, 40 LES isolates were analysed. We
found signiﬁcant changes in the phenotypic and genotypic properties of the LES
populations during the sampling period. Variations in morphotype distribution,
the production of quorum sensing-dependent exoproducts pyocyanin and LasA,
antibiotic resistance proﬁles, and levels of auxotrophy and hypermutability were
observed. We used PCR assays to screen for the presence of novel regions of
the LES genome, including four prophages and a unique genomic island. There
were signiﬁcant changes in the prevalence of the novel genomic island during
the sampling period. Using PCR assays we were able to detect three of the LES
prophages in ﬁlter-sterilised, DNase I-treated sputum. This study indicates that
signiﬁcant levels of population ﬂuctuation occur during periods of pulmonary
exacerbation and IV antibiotic therapy.
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Infection of the lungs by P. aeruginosa signiﬁcantly increases the morbidity asso-
ciated with cystic ﬁbrosis (CF), and once infection is established, it is impossible
to eradicate. The Liverpool Epidemic Strain (LES) was ﬁrst identiﬁed in 1996 and
has been linked with increased morbidity of CF patients, superinfection, and the
infection of non-CF parents of a CF patient. In Liverpool, up to 80% of adult
CF patients infected with P. aeruginosa harbour the LES and identiﬁcation of this
strain leads to segregation of patients. In many clinical laboratories, two typing
methods are used to identify the LES, the published PCR tests (PS21 and LES-
F9) and pulsed ﬁeld gel electrophoresis (PFGE). Using these typing methods, 25
anomalous isolates from the Liverpool Adult CF Unit, Papworth Hospital and the
Health Protection Agency, were identiﬁed that gave inconsistent results with regards
to either PFGE or PCR tests. The Clondiag tube array genomotyping system was
used on these isolates to determine small nucleotide polymorphisms (SNPs) in
the core genome of P. aeruginosa. This method enabled us to determine whether
the isolates shared the same genomic backbone as the LES. Of the 25 anamolous
isolates tested, 13 isolates were found to be the LES using this system. Both false
positives and false negatives using the two accepted tests (PCR and PFGE) were
detected. The rapidly evolving nature of the LES suggests that correct identiﬁcation
could be a challenging task for clinical laboratories in the future.
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The Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa was ﬁrst re-
ported in 1996, after the spread of a drug-resistant strain amongst patients at a
children’s CF unit in Liverpool. The strain is widespread in the UK and appears to
have unusual characteristics. It has caused infections of both non-CF parents of a
CF patient, and the pet cat of another CF patient. In addition, there is evidence that
adult patients infected with the LES suffer greater morbidity. We have determined
the whole genome sequence for the earliest available isolate of the LES (LESB58,
from 1988). The strain contains four novel prophage gene clusters, with evidence of
recombination between the clusters. In addition to genomic islands similar to PAGI-
1 and PAGI-2, the LES genome also carries a novel island (LESGI-7). Signature-
tagged mutagenesis (STM) using a rat model of chronic infection has enabled us
to identify mutations causing attenuation of virulence. Some STM mutations map
to novel prophages/genomic islands suggesting that these regions play a role in the
pathogenicity of the LES.
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Sequence analysis of the OprD gene of a worldwide collection of Pseudomonas
aeruginosa strains indicated that the cystic ﬁbrosis patient isolates mostly belong
to a well-delineated OprD genotype (designated OprD type B). This genotype is
present in only 30% of other P. aeruginosa strains, like environmental strains and
strains isolated from other clinical cases.
In the current study we investigated whether this OprD type is predominantly present
in the isolates of the chronically colonized CF patients in our hospital.
In a follow-up study of 160 CF patients during a 5 years period (2002–2007) the
different isolates of each patient were compared by RAPD-analysis and ﬂuorescent
AFLP analysis. When the same genotype was present in the samples of one patient
during at least 6 months, the patient was considered as chronically colonized with
this strain. A total of 51 patients were considered chronically colonized. Sequence
analysis of the OprD gene of these strains, by either a speciﬁc PCR for the OprD
gene type B and/or OprD gene sequencing demonstrated that 46 of the 51 strains
(90%) belonged to the OprD type B group.
Conclusion: Whereas different P. aeruginosa OprD genotypes are present in the
environment, of which approximately 30% belong to genotype B, long term colo-
nization is predominantly caused by OprD genotype B isolates. Further research will
indicate whether the OprD is more than a mere marker for long term colonization.
